Androgen effects on body composition

Growth Hormone and IGF Research

Volumn 13, Issue SUPPL. A, 2003, Pages

  Bhasin, Shalender ^a,b   Woodhouse, Linda ^a,b   Storer, Thomas W ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b El Camino College   (United States)

Author keywords

Androgen; Athletic performance; Body fat; Eugonadal; Exercise; Hypogonadal; Muscle mass; Stacking; Steroids; Testosterone

Indexed keywords

ANABOLIC AGENT; ANDROGEN; GONADORELIN AGONIST; NANDROLONE DECANOATE; OXANDROLONE; OXYMETHOLONE; PLACEBO; STANOZOLOL; TESTOSTERONE CIPIONATE; TESTOSTERONE DERIVATIVE; TESTOSTERONE ESTER;

AUTOIMMUNE DISEASE; BODY COMPOSITION; BODY FAT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; KIDNEY FAILURE; LIPID METABOLISM; MALE; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL;

EID: 0141854355     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00058-3     Document Type: Article

References (71)

1. J.D. Wilson, Androgen abuse by athletes, Endocr. Rev. 9 (1988) 181-199.
2. C.W. Bardin, The anabolic action of testosterone, N. Engl. J. Med. 335 (1996) 52-53.
3. S. Bhasin, T.W. Storer, N. Berman, K.E. Yarasheski, B. Clevenger, J. Phillips, W.P. Lee, T.J. Bunnell, R. Casaburi, Testosterone replacement increases fat-free mass and muscle size in hypogonadal men, J. Clin. Endocrinol. Metab. 82 (1997) 407-413.
4. S. Bhasin, T.W. Storer, N. Berman, C. Callegari, B.A. Clevenger, J. Phillips, T. Bunnell, R. Tricker, A. Shirazi, R. Casaburi, The effects of supraphysiologic doses of testosterone on muscle size and strength in men, N. Engl. J. Med. 335 (1996) 1-7.
5. I.G. Brodsky, P. Balagopal, K.S. Nair, Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - a clinical research center study, J. Clin. Endocrinol. Metab. 81 (1996) 3469-3475.
6. C. Wang, R.S. Swerdloff, A. Iranmanesh, A. Dobs, P.J. Snyder, G. Cunningham, A.M. Matsumoto, T. Weber, N. Berman, the Testosterone Gel Study Group, Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group, J. Clin. Endocrinol. Metab. 85 (2000) 2839-2853.
7. C. Wang, D.R. Eyre, R. Clark, D. Kleinberg, C. Newman, A. Iranmanesh, J. Veldhuis, R.E. Dudley, N. Berman, T. Davidson, T.J. Barstow, R. Sinow, G. Alexander, R.S. Swerdloff, Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone resorption markers in hypogonadal men: a Clinical Research Center Study, J. Clin. Endocrinol. Metab. 81 (1996) 3654-3662.
8. L. Katznelson, J.S. Finkelstein, D.A. Schoenfeld, D.I. Rosenthal, E.J. Anderson, A. Klibanski, Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism, J. Clin. Endocrinol. Metab. 81 (1996) 4358-4365.
9. P.J. Snyder, H. Peachey, J.A. Berlin, P. Hannoush, G. Haddad, A. Dlewati, J. Santanna, L. Loh, D.A. Lenrow, J.H. Holmes, S.C. Kapoor, L.E. Atkinson, B.L. Strom, Effects of testosterone replacement in hypogonadal men, J. Clin. Endocrinol. Metab. 85 (2000) 2670-2677.
10. L. Katznelson, D.I. Rosenthal, M.S. Rosol, E.J. Anderson, D.L. Hayden, D.A. Schoenfeld, A. Klibanski, Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism, Am. J. Roentgenol. 170 (1998) 423-427.
11. N. Mauras, V. Hayes, S. Welch, A. Rini, K. Helgeson, M. Dokler, J.D. Veldhuis, R.J. Urban, Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength and adiposity, J. Clin. Endocrinol. Metab. 83 (1998) 1886-1892.
12. J.E. Morley, H.M. Perry III, F.E. Kaiser, D. Kraenzle, J. Jensen, K. Houston, M. Mattammal, H.M. Perry Jr., Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study, J. Am. Geriatr. Soc. 41 (1993) 149-152.
13. J.E. Morley, F. Kaiser, W.J. Raum, H.M. Perry III, J.F. Flood, J. Jensen, A.J. Silver, E. Roberts, Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone, Proc. Natl. Acad. Sci. USA 94 (1997) 7537-7542.
14. C.D. Kochakian, Comparison of protein anabolic properties of various androgens in the castrated rat, Am. J. Physiol. 60 (1950) 553-558.
15. A.T. Kenyon, K. Knowlton, I. Sandiford, F.C. Kock, G. Lotwin, A comparative study of the metabolic effects of testosterone propionate in normal men and women and in eunuchoidism, Endocrinology 26 (1940) 26-45.
16. J.L. Tenover, Experience with testosterone replacement in the elderly, Mayo Clin. Proc. 75 (Suppl.) (2000) S77-S81.
17. R. Casaburi, T. Storer, S. Bhasin, Androgen effects on body composition and muscle performance, in: S. Bhasin, H. Gabelnick, J.M. Spieler, R.S. Swerdloff, C. Wang (Eds.), Pharmacology, Biology, and Clinical Applications of Androgens: Current Status and Future Prospects, Wiley-Liss, New York, NY, 1996, pp. 283-288.
18. R.C. Griggs, W. Kingston, R.F. Josefowicz, B.E. Herr, G. Forbes, D. Halliday, Effect of testosterone on muscle mass and muscle protein synthesis, J. Appl. Physiol. 66 (1989) 498-503.
19. R.C. Griggs, S. Pandya, J.M. Florence, M.H. Brooke, W. Kingston, J.P. Miller, J. Chutkow, B.E. Herr, R.T. Moxley, Randomized controlled trial of testosterone in myotonic dystrophy, Neurology 39 (1989) 219-222.
20. N.R. Young, H.W. Baker, G. Liu, E. Seeman, Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception, J. Clin. Endocrinol. Metab. 77 (1993) 1028-1032.
21. J.S. Tenover, Effects of testosterone supplementation in the aging male, J. Clin. Endocrinol. Metab. 75 (1992) 1092-1098.
22. P.J. Snyder, H. Peachey, P. Hannoush, J.A. Berlin, L. Loh, D.A. Lenrow, J.H. Holmes, A. Dlewati, J. Santanna, C.J. Rosen, B.L. Strom, Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age, J. Clin. Endocrinol. Metab. 84 (1999) 2647-2653.
23. R. Sih, J.E. Morley, F.E. Kaiser, H.M. Perry III, P. Patrick, C. Ross, Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial, J. Clin. Endocrinol. Metab. 82 (1997) 1661-1667.
24. A.M. Kenny, K.M. Prestwood, C.A. Gruman, K.M. Marcello, L.G. Raisz, Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, J. Gerontol. A 56 (2001) M266-M272.
25. A.A. Ferrando, M. Sheffield-Moore, C.W. Yeckel, C. Gilkison, J. Jiang, A. Achacosa, S.A. Lieberman, K. Tipton, R.R. Wolfe, R.J. Urban, Testosterone administration to older men improves muscle function: molecular and physiological mechanisms, Am. J. Physiol. Endocrinol. Metab. 282 (2002) E601- E607.
26. J.S. Tenover, Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men, Baillieres Clin. Endocrinol. Metab. 12 (1998) 419-425.
27. S. Bhasin, T.W. Storer, M. Javanbakht, N. Berman, K.E. Yarasheski, J. Phillips, M. Dike, I. Sinha-Hikim, R. Shen, R.D. Hays, G. Beall, Effects of testosterone replacement and resistance exercise on muscle strength, and body composition in human immunodeficiency virus-infected men with weight loss and low testosterone levels, JAMA 283 (2000) 763-770.
28. S. Bhasin, T.W. Storer, N. Asbel-Sethi, A. Kilbourne, R. Hays, I. Sinha-Hikim, R. Shen, S. Arver, G. Beall, Effects of testosterone replacement with a non-genital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels, J. Clin. Endocrinol. Metab. 83 (1998) 3155-3162.
29. S. Bhasin, M. Javanbakht, Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection? J. Parenter. Enteral Nutr. 23 (1999) S195-S201.
30. S. Grinspoon, C. Corcoran, H. Askari, D. Schoenfeld, L. Wolf, B. Burrows, M. Walsh, D. Hayden, K. Parlman, E. Anderson, N. Basgoz, A. Klibanski, Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial, Ann. Intern. Med. 129 (1998) 18-26.
31. A.S. Dobs, J. Cofrancesco, W.E. Nolten, A. Danoff, R. Anderson, C.D. Hamilton, J. Feinberg, D. Seekins, B. Yangco, F. Rhame, The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection, Am. J. Med. 107 (1999) 126-132.
32. G.O. Coodley, M.K. Coodley, A trial of testosterone therapy for HIV-associated weight loss, AIDS 11 (1997) 1347-1352.
33. A. Strawford, T. Barbieri, R. Neese, M. Van Loan, M. Christiansen, R. Hoh, G. Sathyan, R. Skowronski, J. King, M. Hellerstein, Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20 (1999) 137-146.
34. F.R. Sattler, S.V. Jaque, E.T. Schroeder, C. Olson, M.P. Dube, C. Martinez, W. Briggs, R. Horton, S. Azen, Effect of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with the human immunodeficiency virus, J. Clin. Endocrinol. Metab. 84 (1999) 1268-1276.
35. A. Strawford, T. Barbieri, M. Van Loan, E. Parks, D. Catlin, N. Barton, R. Neese, M. Christiansen, J. King, M.K. Hellerstein, Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss, JAMA 281 (1999) 1282-1290.
36. D.J. Handelsman, Q. Dong, Hypothalamic-pituitary-gonadal axis in chronic renal failure, Endocrinol. Metab. Clin. North Am. 22 (1993) 145-161.
37. D.J. Handelsman, P.Y. Liu, Androgen therapy in chronic renal failure, Baillieres Clin. Endocrinol. Metab. 12 (1998) 485-500.
38. K.L. Johansen, K. Mulligan, M. Schambelan, Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial, JAMA 281 (1999) 1275-1281.
39. R.W. Jones, M.M. El Bishti, S.R. Bloom, J. Burke, J.E. Carter, R. Counahan, R.N. Dalton, M.C. Morris, C. Chantler, The effects of anabolic steroids on growth, body composition, and metabolism in boys with chronic renal failure on regular hemodialysis, J. Pediatr. 97 (1980) 559-566.
40. K.M. Kassmann, R. Rappaport, M. Broyer, The short term effect of testosterone on growth in boys on hemodialysis, Clin. Nephrol. 37 (1992) 148-154.
41. J.S. Berns, M.R. Rudnick, R.M. Cohen, A controlled trial of recombinant erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis, Clin. Nephrol. 37 (1992) 264-267.
42. D. Buchwald, S. Argyres, R.E. Easterling, F.J. Oelshlegel Jr., G.J. Brewer, E.B. Schoomaker, P.H. Abbrecht, G.W. Williams, J.M. Weller, Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients, Nephron 18 (1977) 232-238.
43. J.L. Williams, J.H. Stein, T.F. Ferris, Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study, Arch. Intern. Med. 134 (1974) 289-292.
44. I.R. Reid, H.K. Ibbertson, J.T. France, J. Pybus, Plasma testosterone concentrations in asthmatic men treated with glucocorticoids, Br. Med. J. 291 (1985) 574.
45. I.R. Reid, D.J. Wattie, M.C. Evans, J.P. Stapleton, Testosterone therapy in glucocorticoid-treated men, Arch. Intern. Med. 156 (1996) 1173-1177.
46. M.R. McAdams, R.H. White, B.E. Chipps, Reduction of serum testosterone levels during chronic glucocorticoid therapy, Ann. Intern. Med. 104 (1986) 648-651.
47. R. Casaburi, S. Goren, S. Bhasin, Substantial prevalence of low anabolic hormone levels in COPD patients undergoing rehabilitation, Am. J. Respir. Crit. Care Med. 153 (1996) A128.
48. G.S. Pape, M. Friedman, L.E. Underwood, D.R. Clemmons, The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease, Chest 99 (1991) 1495-1500.
49. C. Pichard, U. Kyle, J.C. Chevrolet, Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective randomized controlled study, Crit. Care Med. 24 (1996) 403-413.
50. L. Burdet, B. de Muralt, Y. Schutz, C. Pichard, J.W. Fitting, Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study, Am. J. Respir. Crit. Care Med. 156 (1997) 1800-1806.
51. A.M.W. Schols, P.B. Soeters, R. Mostert, Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 152 (1995) 1268-1274.
52. R. Casaburi, G. Corsentino, S. Bhasin, M. Fournier, M. Lewis, J. Porszasz, T. Storer, A randomized trial of strength training and testosterone supplementation in men with chronic obstructive pulmonary disease, Eur. Respir. J. 18 (Suppl. 33) (2001) 173S.
53. S. Bhasin, L. Woodhouse, T.W. Storer, Proof of the effect of testosterone on skeletal muscle, J. Endocrinol. 170 (2001) 27-38.
54. J. Antonio, J.D. Wilson, F.W. George, Effects of castration and androgen treatment on androgen-receptor levels in rat skeletal muscles, J. Appl. Physiol. 87 (1999) 2016-2019.
55. E. Dahlberg, M. Snochowski, J.A. Gustafsson, Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol, Endocrinology 108 (1981) 1431-1440.
56. N.E. Rance, S.R. Max, Modulation of the cytosolic androgen receptor in striated muscle by sex steroids, Endocrinology 115 (1984) 862-866.
57. S. Bhasin, L. Woodhouse, R. Casaburi, A.B. Singh, D. Bhasin, N. Berman, X. Chen, K.E. Yarasheski, L. Magliano, C. Dzekov, J. Dzekov, R. Bross, J. Phillips, I. Sinha-Hikim, R. Shen, T.W. Storer, Testosterone dose-response relationships in healthy young men, Am. J. Physiol. Endocrinol. Metab. 281 (2001) E1172-E1181.
58. A.B. Singh, S. Hsia, P. Alaupovic, I. Sinha-Hikim, L. Woodhouse, T.A. Buchanan, R. Shen, R. Bross, N. Berman, S. Bhasin, The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men, J. Clin. Endocrinol. Metab. 87 (2002) 136-143.
59. R.J. Urban, Y.H. Bodenburg, C. Gilkison, J. Foxworth, A.R. Coggan, R.R. Wolfe, A. Ferrando, Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis, Am. J. Physiol. 269 (1995) E820-E826.
60. I. Sinha-Hikim, J. Artaza, L. Woodhouse, N. Gonzalez-Cadavid, A.B. Singh, M.I. Lee, T.W. Storer, R. Casaburi, R. Shen, S. Bhasin, Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy, Am. J. Physiol. Endocrinol. Metab. 283 (2002) E154-E164.
61. T. Saartok, E. Dahlberg, J.A. Gustaffsson, Relative binding affinity of anabolic-androgenic steroids, comparison of the binding to the androgen receptors in skeletal muscle and in prostate as well as sex hormone binding globulin, Endocrinology 114 (1984) 2100-2107.
62. M. Konagaya, S.R. Max, A possible role for endogenous glucocorticoid in orchiectomy-induced atrophy of the rat levator ani muscle: studies with RU38486, a potent glucocorticoid antagonist, J. Steroid Biochem. 25 (1986) 305-311.
63. D.A. Fryburg, A. Weltman, L.A. Jahn, Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes, J. Clin. Endocrinol. Metab. 82 (1997) 3710-3719.
64. M. Leslie, N.G. Forger, S.M. Breedlove, Sexual dimorphism and androgen effects on spinal motorneurons innervating the rat flexor digitorum, brevis, Brain Res. 561 (1991) 269-273.
65. C.E. Blanco, P. Popper, P. Micevych, Anabolic-androgenic steroid induced alterations in choline acetyltransferase messenger RNA levels of spinal cord motorneurons in the male rat, Neuroscience 78 (1997) 873-882.
66. W. Bartsch, M. Krieg, K.D. Voigt, Quantitation of endogenous testosterone, 5-alpha-dihydrotestosterone and 5-alpha-androstane-3-alpha, 17-beta-diol in subcellular fractions of the prostate, bulbocavernosus/levator ani muscle, skeletal muscle, and heart muscle of the rat, J. Steroid Biochem. 13 (1980) 259-267.
67. F. Sattler, W. Briggs, I. Antonipillai, J. Allen, R. Horton, Low dihydrotestosterone and weight loss in the AIDS wasting syndrome, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 (1998) 246-251.
68. J. Seidell, P. Bjorntorp, L. Sjostrom, H. Kvist, R. Sannerstedt, Visceral fat accumulation in men is positively associated with insulin, glucose and C-peptide levels, but negatively with testosterone levels, Metabolism 39 (1990) 897-901.
69. E. Barrett-Connors, K.-T. Khaw, Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study, Circulation 78 (1988) 539-545.
70. P. Marin, M. Krotkiewski, P. Bjorntorp, Androgen treatment of middle-aged, obese men: effects on metabolism, muscle, and adipose tissues, Eur. J. Med. 1 (1992) 329-336.
71. P. Marin, B. Oden, P. Bjorntorp, Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens, J. Clin. Endocrinol. Metab. 80 (1995) 239-243.